Form EFFECT Clearmind Medicine Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 26, 2026 4:00 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clearmind completes patient recruitment for AUD drug trial cohort
- Uptime Institute Signs Memorandum of Understanding (MOU) with Indonesian Data Center Providers Association (IDPRO) to Advance Indonesia's Data Center Industry
- FTI Consulting Appoints Daniel Heywood as Senior Managing Director in Brisbane
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share